Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical development ....
Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than $552,362 of personal cash previously advanced to IGC....
). Item 1.01 Entry into a MaterialDefinitive Agreement. On June 30, 2026, IGC Pharma, Inc ...Mukunda and Ms ...The Company issued 2,226,475 shares of common stock to Mr ... The Company issued 2,048,378 shares of common stock to Ms ... Mukunda or Ms ... IGC Pharma Inc.
Leading the group is IGC Pharma, Inc ... IGC), which recently introduced its proprietary AI-powered Agentic Harmonization Assistant (AHA) ... The announcement comes as IGC advances its lead Phase 2 ...
KNDI), and IGC Pharma (NYSEAmerican. IGC), each benefiting from corporate initiatives that position them within some of today's fastest-growing technology sectors ... IGC Pharma (NYSE American. IGC) ...